BCL-Illumina Reagents-Illumina-Micro-Sole Source

The Alabama Bureau of Clinical Laboratories is seeking to procure a comprehensive range of Illumina sequencing reagents and laboratory consumables through a sole source procurement, designated as BCL-Illumina Reagents-Illumina-Micro-Sole Source. This Quick Quote solicitation, posted on April 3, 2026, with a response deadline of April 8, 2026, involves the acquisition of an extensive list of Illumina products including DNA prep kits (20060060, 20060059), DNA/RNA universal dual indexes sets A through D, MiSeq reagent kits across various cycle capacities (v2 300-cycles, v2 500-cycles, Nano and Micro variants), NextSeq reagent kits (550Dx High Output v2.5 and NextSeq 1000/2000 P1-P4 XLEAP-SBS kits), iSeq 100 reagent kits, MiniSeq reagent kits in multiple output configurations, specialized testing kits such as the Illumina COVIDSeq Test (3072 samples), and respiratory virus enrichment kits. Suppliers must register in the Alabama Buys procurement system and submit responses electronically by the April 8, 2026 deadline. Key supplier obligations include certification of Alabama sales tax registration compliance, E-Verify enrollment verification for Alabama-based employees, disclosure statements for contracts exceeding $25,000, and certification that the company is not debarred or suspended from government contracting. The State reserves the right to conduct cost realism and price reasonableness analyses as evaluation criteria.

This solicitation is designated as a sole source procurement, indicating that only Illumina products meet the specific technical requirements of the Bureau's laboratory operations, which limits competition to Illumina or authorized distributors of Illumina products. Suppliers must comply with the Beason-Hammon Alabama Taxpayer and Citizen Protection Act regarding immigration law compliance and accept multiple forms of electronic payment without additional charges. The procurement framework is governed by Alabama law with venue in Montgomery, and the State explicitly retains sovereign immunity while disclaiming indemnification obligations. All products are subject to inspection and acceptance prior to payment. No specific award value or budget range is disclosed in the available documentation, though the comprehensive scope of reagents and consumables across multiple sequencing platforms suggests a significant procurement value. Interested vendors should review the QQ Standard Boilerplate terms and conditions document for complete operational and legal requirements governing this Quick Quote solicitation.